{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:15:07Z","timestamp":1790313307871,"version":"4.1.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Financial burden has emerged as a significant challenge in oncology, adversely affecting patients\u2019 quality of life, treatment adherence, and long-term outcomes. While research on cancer-related financial toxicity (FT) has grown rapidly, a comprehensive bibliometric analysis of its knowledge structure, thematic evolution, and emerging trends remains scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications on FT among cancer patients, published from 2003 to January 19, 2026, were retrieved from the Web of Science Core Collection and Scopus databases. Bibliometric and science mapping analyses were conducted using CiteSpace, VOSviewer, and R software to assess publication trends, collaboration networks, research hotspots, and thematic evolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Research on FT in cancer patients has experienced substantial growth over the past two decades, with increasing interdisciplinary integration. The focus has shifted from descriptive economic burden assessments to patient-centered and system-oriented approaches, conceptualizing FT as a modifiable risk embedded within social and clinical contexts. Social support and multidisciplinary management have emerged as major interconnected research hotspots, emphasizing that effective mitigation of FT requires addressing both upstream social determinants of health and downstream integration of coordinated clinical interventions. Emerging keywords suggest that measurement and conceptualization, behavioral consequences, socioeconomic impact, and intervention &amp;amp; health system response are likely to influence future research directions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This bibliometric analysis reveals that FT research has evolved into a comprehensive conceptual framework, positioning FT as a modifiable, system-level risk in cancer care. By synthesizing evidence on social support and multidisciplinary management, this study proposes a model linking social determinants, clinical assessment, and coordinated interventions. These findings offer valuable insights to guide future research and the development of targeted strategies aimed at alleviating financial burden and improving survivorship care, supporting the integration of FT management into patient-centered oncology practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1806145","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:37:00Z","timestamp":1780897020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["From economic burden to patient-centered solutions: the evolving landscape of financial toxicity in oncology"],"prefix":"10.3389","volume":"14","author":[{"given":"Luya","family":"Shi","sequence":"first","affiliation":[{"name":"Municipal Hospital Affiliated to Taizhou University","place":["Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xinjiang Clinical Research Center for Perinatal Diseases, Urumqi Maternal and Child Health Hospital","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Sun","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Dai","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"ref1","first-page":"80","article-title":"Financial toxicity, part I: a new name for a growing problem","volume":"27","author":"Zafar","year":"2013","journal-title":"Oncology (Williston Park)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3322\/caac.70011","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2255388","DOI":"10.1001\/jamanetworkopen.2022.55388","article-title":"Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis","volume":"6","author":"Ehsan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"djw205","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/S2214-109X(19)30463-2","article-title":"A comprehensive assessment of universal health coverage in 111 countries: a retrospective observational study","volume":"8","author":"Wagstaff","year":"2020","journal-title":"Lancet Glob Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/jnci\/djab192","article-title":"Annual report to the nation on the status of cancer, part 2: patient economic burden associated with cancer care","volume":"113","author":"Yabroff","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s00520-025-09252-9","article-title":"Prevalence and impact of financial toxicity in older patients with cancer: a prospective observational study in India","volume":"33","author":"Noronha","year":"2025","journal-title":"Support Care Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21730","article-title":"Navigating financial toxicity in patients with cancer: a multidisciplinary management approach","volume":"72","author":"Smith","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100269","DOI":"10.1016\/j.eclinm.2020.100269","article-title":"Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions","volume":"20","author":"Desai","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00520-025-09591-7","article-title":"Assessment of financial toxicity in patients with cancer in Slovenia","volume":"33","author":"Voros","year":"2025","journal-title":"Support Care Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1200\/JCO.22.01799","article-title":"Financial toxicity in cancer care: implications for clinical care and potential practice solutions","volume":"41","author":"Khan","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.eururo.2024.12.002","article-title":"The financial burden of localized and metastatic bladder cancer","volume":"87","author":"Scilipoti","year":"2025","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1113977","DOI":"10.3389\/fendo.2023.1113977","article-title":"Thyroid nodules: global, economic, and personal burdens","volume":"14","author":"Uppal","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e2250211","DOI":"10.1001\/jamanetworkopen.2022.50211","article-title":"Estimated indirect cost savings of using telehealth among nonelderly patients with cancer","volume":"6","author":"Patel","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102992","DOI":"10.1016\/j.esmoop.2024.102992","article-title":"ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer","volume":"9","author":"Carrera","year":"2024","journal-title":"ESMO Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cgh.2023.07.018","article-title":"Financial burden of hepatocellular carcinoma screening in patients with cirrhosis","volume":"22","author":"Narasimman","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.bpg.2023.101839","article-title":"Colorectal cancer: a health and economic problem","volume":"66","author":"Klimeck","year":"2023","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J Bus Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e33239","DOI":"10.1097\/MD.0000000000033239","article-title":"Financial toxicity of breast cancer over the last 30 years: a bibliometrics study and visualization analysis via CiteSpace","volume":"102","author":"Cheng","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2478\/raon-2025-0002","article-title":"The financial toxicity of breast cancer: a systematic mapping of the literature and identification of research challenges","volume":"59","author":"Ratosa","year":"2025","journal-title":"Radiol Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/asi.21309","article-title":"The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis","volume":"61","author":"Chen","year":"2010","journal-title":"J Am Soc Inf Sci Technol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e0223994","DOI":"10.1371\/journal.pone.0223994","article-title":"Visualizing a field of research: a methodology of systematic scientometric reviews","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc Inf Sci Technol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (cost)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States","volume":"100","author":"Yabroff","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the cost measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jnci\/djh255","article-title":"Burden of illness in cancer survivors: findings from a population-based national sample","volume":"96","author":"Yabroff","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","article-title":"Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors","volume":"34","author":"Yabroff","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","article-title":"A systematic review of financial toxicity among cancer survivors: we can't pay the co-pay","volume":"10","author":"Gordon","year":"2017","journal-title":"Patient"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/tbm\/ibab091","article-title":"Financial toxicity in cancer care: origins, impact, and solutions","volume":"11","author":"Abrams","year":"2021","journal-title":"Transl Behav Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s11192-015-1645-z","article-title":"The bibliometric analysis of scholarly production: how great is the impact?","volume":"105","author":"Ellegaard","year":"2015","journal-title":"Scientometrics"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","article-title":"Cancer situation in China: an analysis based on the global epidemiological data released in 2024","volume":"45","author":"Diao","year":"2025","journal-title":"Cancer Commun"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e35833","DOI":"10.1002\/cncr.35833","article-title":"Annual report to the nation on the status of cancer, featuring state-level statistics after the onset of the COVID-19 pandemic","volume":"131","author":"Sherman","year":"2025","journal-title":"Cancer"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/jnci\/djab013","article-title":"Medical financial hardship in survivors of adolescent and young adult cancer in the United States","volume":"113","author":"Lu","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jnci\/djac044","article-title":"Association of Medical Financial Hardship and Mortality among cancer survivors in the United States","volume":"114","author":"Yabroff","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/jnci\/djac134","article-title":"Addressing transportation insecurity among patients with cancer","volume":"114","author":"Graboyes","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NNR.0000000000000831","article-title":"Qualitative evaluation of financial toxicity and supportive care needs of women living with metastatic breast Cancer","volume":"74","author":"Marshall","year":"2025","journal-title":"Nurs Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/TA.0000000000004247","article-title":"The invisible scars: unseen financial complications worsen every aspect of long-term health in trauma survivors","volume":"96","author":"Ilkhani","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12955-022-01987-x","article-title":"Patient reported outcomes in oncology: changing perspectives-a systematic review","volume":"20","author":"Silveira","year":"2022","journal-title":"Health Qual Life Outcomes"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e000783","DOI":"10.1136\/bmjonc-2025-000783","article-title":"Patient-reported outcomes (Pros) in clinical trials and in clinical practice: report from the xxi National Conference of the Italian Association of Medical Oncology (Aiom)","volume":"4","author":"Puccini","year":"2025","journal-title":"BMJ Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/S1470-2045(21)00588-X","article-title":"A comprehensive framework for early-onset colorectal cancer research","volume":"23","author":"Eng","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1016\/S2468-2667(21)00232-2","article-title":"Health and financial costs of adverse childhood experiences in 28 European countries: a systematic review and Meta-analysis","volume":"6","author":"Hughes","year":"2021","journal-title":"Lancet Public Health"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.lanepe.2024.101171","article-title":"Mapping the landscape of biliary tract cancer in Europe: challenges and controversies","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1806145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:37:01Z","timestamp":1780897021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1806145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":49,"alternative-id":["10.3389\/fpubh.2026.1806145"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1806145","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1806145"}}